|
1
|
Annane D, Bellissant E and Cavaillon JM:
Septic shock. Lancet. 365:63–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chung CS, Watkins L, Funches A,
Lomas-Neira J, Cioffi WG and Ayala A: Deficiency of gammadelta T
lymphocytes contributes to mortality and immunosuppression in
sepsis. Am J Physiol Regul Integr Comp Physiol. 291:R1338–R1343.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wisnoski N, Chung CS, Chen Y, Huang X and
Ayala A: The contribution of CD4+ CD25+
T-regulatory-cells to immune suppression in sepsis. Shock.
27:251–257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang LN, Yao YM and Sheng ZY: The role of
regulatory T cells in the pathogenesis of sepsis and its clinical
implication. J Interferon Cytokine Res. 32:341–349. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Inoue S, Suzuki-Utsunomiya K, Okada Y,
Taira T, Iida Y, Miura N, Tsuji T, Yamagiwa T, Morita S, Chiba T,
et al: Reduction of immunocompetent T cells followed by prolonged
lymphopenia in severe sepsis in the elderly. Crit Care Med.
41:810–819. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Drewry AM, Samra N, Skrupky LP, Fuller BM,
Compton SM and Hotchkiss RS: Persistent lymphopenia after diagnosis
of sepsis predicts mortality. Shock. 42:383–391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le Tulzo Y, Pangault C, Gacouin A,
Guilloux V, Tribut O, Amiot L, Tattevin P, Thomas R, Fauchet R and
Drénou B: Early circulating lymphocytes apoptosis in septic shock
is associated with poor outcome. Shock. 18:487–494. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Turrel F, Guignant C, Venet F, Lepape A
and Monneret G: Innovative therapeutic strategies for restoring
lymphocyte functions in septic patients. Inflamm Allergy Drug
Targets. 7:181–186. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Annane D, Bellissant E, Bollaert PE,
Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M
and Meduri GU: Corticosteroids in the treatment of severe sepsis
and septic shock in adults: A systematic review. JAMA.
301:2362–2375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Keh D, Boehnke T, Weber-Cartens S, Schulz
C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ and Gerlach H:
Immunologic and hemodynamic effects of ‘low-dose’ hydrocortisone in
septic shock: A double-blind, randomized, placebo-controlled,
crossover study. Am J Respir Crit Care Med. 167:512–520. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Davis TE, Kis-Toth K, Szanto A and Tsokos
GC: Glucocorticoids suppress T cell function by up-regulating
microRNA-98. Arthritis Rheum. 65:1882–1890. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smith LK, Shah RR and Cidlowski JA:
Glucocorticoids modulate microRNA expression and processing during
lymphocyte apoptosis. J Biol Chem. 285:36698–36708. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodriguez A, Vigorito E, Clare S, Warren
MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska
EA, et al: Requirement of bic/microRNA-155 for normal immune
function. Science. 316:608–611. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang HJ, Zhang PJ, Chen WJ, Jie D, Dan F,
Jia YH and Xie LX: Characterization and identification of novel
serum microRNAs in sepsis patients with different outcomes. Shock.
39:480–487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao R, Ma YL, Liang W, Li HH, Ma ZJ, Yu X
and Liao YH: MicroRNA-155 modulates Treg and Th17 cells
differentiation and Th17 cell function by targeting SOCS1. PLoS
One. 7:e460822012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu R, Huffaker TB, Kagele DA, Runtsch MC,
Bake E, Chaudhuri AA, Round JL and O'Connell RM: MicroRNA-155
confers encephalogenic potential to Th17 cells by promoting
effectorgene expression. J Immunol. 190:5972–5980. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li K, Du Y, Jiang BL and He JF: Increased
microRNA-155 and decreased microRNA-146a may promote ocular
inflammation and proliferation in Graves' ophthalmopathy. Med Sci
Monit. 20:639–643. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Malmhäll C, Alawieh S, Lu Y, Sjöstrand M,
Bossios A, Eldh M and Rådinger M: MicroRNA-155 is essential for
T(H)2-mediated allergen-induced eosinophilic inflammation in the
lung. J Allergy Clin Immunol. 133:1429–1438. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J and Gong J, Li P, Li M, Liu Y, Liang
S and Gong J: Knockdown of microRNA-155 in kupffer cells results in
immunosuppressive effects and prolongs survival of mouse liver
allografts. Transplantation. 97:626–635. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Cheng Y, Cui W, Li M, Li B and
Guo L: MicroRNA-155 modulates Th1 and Th17 cell differentiation and
is associated with multiple sclerosis and experimental autoimmune
encephalomyelitis. J Neuroimmunol. 266:56–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tili E, Michaille JJ, Cimino A, Costinean
S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA and
Croce CM: Modulation of miR-155 and miR-125b levels following
lipopolysaccharide/TNF-alpha stimulation and their possible roles
in regulating the response to endotoxin shock. J Immunol.
179:5082–5089. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Piccinini AM and Midwood KS: Endogenous
control of immunity against infection: Tenascin-C regulates
TLR4-mediated inflammation via microRNA-155. Cell Rep. 2:914–926.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang ZH, Liang YB, Tang H, Chen ZB, Li ZY,
Hu XC and Ma ZF: Dexamethasone down-regulates the expression of
microRNA-155 in the livers of septic mice. PLoS One. 8:e805472013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dunand-Sauthier I, Irla M, Carnesecchi S,
Seguín-Estévez Q, Vejnar CE, Zdobnov EM, Santiago-Raber ML and
Reith W: Repression of arginase-2 expression in dendritic cells by
microRNA-155 is critical for promoting T cell proliferation. J
Immunol. 193:1690–1700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Feng Z, Xia Y, Zhang M and Zheng J:
MicroRNA-155 regulates T cell proliferation through targeting GSK3β
in cardiac allograft rejection in a murine transplantation model.
Cell Immunol. 281:141–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dellinger RP, Levy MM, Rhodes A, Annane D,
Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke
R, et al: Surviving Sepsis Campaign Guidelines Committee including
the Pediatric Subgroup. Surviving sepsis campaign: International
guidelines for management of severe sepsis and septic shock. Crit
Care Med. 41:580–637. 2012. View Article : Google Scholar
|
|
27
|
Liu TE, Wang S, Zhang L, Guo L, Yu Z, Chen
C and Zheng J: Growth hormone treatment of premature ovarian
failure in a mouse model via stimulation of the Notch-1 signaling
pathway. Exp Ther Med. 12:215–221. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ceppi M, Pereira PM, Dunand-Sauthier I,
Barras E, Reith W, Santos MA and Pierre P: MicroRNA-155 modulates
the interleukin-1 signaling pathway in activated human
monocyte-derived dendritic cells. Proc Natl Acad Sci USA.
106:2735–2740. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu F, Weidmer A, Liu CG, Volinia S, Croce
CM and Lieberman PM: Epstein-Barr virus-induced miR-155 attenuates
NF-kappaB signaling and stabilizes latent virus persistence. J
Virol. 82:10436–10443. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin Q, Wang X, McBride J, Fewell C and
Flemington E: B-cell receptor activation induces BIC/miR-155
expression through a conserved AP-1 element. J Biol Chem.
283:2654–2662. 2008. View Article : Google Scholar : PubMed/NCBI
|
